Expression and significance of hypoxemia-inducible factor-1α in osteosarcoma of the jaws

被引:20
作者
Chen, Wei-liang [1 ]
Feng, Hong-jie [2 ]
Li, Hai-gang [3 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Oral & Maxillofacial Surg, Guangzhou 510120, Peoples R China
[2] Hangzhou First Peoples Hosp, Dept Oral & Maxillofacial Surg, Hangzhou, Zhejiang, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Pathol, Guangzhou 510120, Peoples R China
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2008年 / 106卷 / 02期
关键词
D O I
10.1016/j.tripleo.2008.01.029
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. The objective of this study was to examine the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in osteosarcoma of the jaw (OSJ) and its relationships with tumoral angiogenesis and clinicopathologic characteristics. Study design. Streptavidin peroxidase immunohistochemical staining was used to detect the expression of HIF-1 alpha and CD34 in paraffin-embedded samples from 25 patients. There were 14 male and 11 female patients, ages ranged from 3 to 63 years. Results. HIF-1 alpha was overexpressed in OSJ. HIF-1 alpha expression was correlated with tumoral microvascular density, as well as with the size, pathologic grade, and clinical stage of OSJ. Expression of HIF-1 alpha was also correlated with clinicopathologic characteristics, such as primary occurrence or recurrence of the tumor, but not with metastasis. Conclusion. HIF-1 alpha was significantly correlated with the size, pathologic grade, clinical stage, and primary occurrence or recurrence of the OSJ. HIF-1 alpha appeared to promote tumoral angiogenesis in OSJ and may be an important target in antitumoral therapy.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 16 条
[1]  
Birner P, 2000, CANCER RES, V60, P4693
[2]  
Birner P, 2001, CANCER, V92, P165, DOI 10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO
[3]  
2-F
[4]   Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma [J].
Bos, R ;
van der Groep, P ;
Greijer, AE ;
Shvarts, A ;
Meijer, S ;
Pinedo, HM ;
Semenza, GL ;
van Diest, PJ ;
van der Wall, E .
CANCER, 2003, 97 (06) :1573-1581
[5]  
ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106
[6]   New targets, drugs, and approaches for the treatment of cancer: An overview [J].
Kerbel, RS .
CANCER AND METASTASIS REVIEWS, 1998, 17 (02) :145-147
[7]   Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer [J].
Koukourakis, MI ;
Giatromanolaki, A ;
Sivridis, E ;
Simopoulos, C ;
Turley, H ;
Talks, K ;
Gatter, KC ;
Harris, AL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1192-1202
[8]   Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage [J].
Kurokawa, T ;
Miyamoto, M ;
Kato, K ;
Cho, Y ;
Kawarada, Y ;
Hida, Y ;
Shinohara, T ;
Itoh, T ;
Okushiba, S ;
Kondo, S ;
Katoh, H .
BRITISH JOURNAL OF CANCER, 2003, 89 (06) :1042-1047
[9]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732
[10]  
WEIDNER N, 1995, AM J PATHOL, V147, P9